Vaximm
1 known investors
Find your way into Vaximm
177 people in our graph share verified history with the Vaximm team — schools, employers, funds. One of them is your warm intro.
Michael Taylorunlockedknows Andreas Niethammer · together at Pfizer (overlapped)
×7knows the team · via Pfizer
×2knows the team · via The Scripps Research Institute
knows the team · via VAXIMM AG
knows the team · via Fate Therapeutics
VAXIMM is a clinical-stage biopharmaceutical company developing oral T-cell immunotherapies for cancer, based on technology invented at UC San Diego. Its lead candidate VXM01 has been evaluated in clinical trials for indications such as pancreatic cancer, and the company operates as a subsidiary of OSR Health.
Founders & leadership
AN
Andreas NiethammerinFounder & Chief Executive OfficerAndreas Niethammer is the founder and chief medical officer of Vaximm, an oral immunotherapy company for cancer, and previously served as chief medical officer at Aardvark Therapeutics in San Diego, where he oversaw translational medicine and clinical development from inception through a public offering. He brings extensive clinical development experience across oncology, immunotherapy, and metabolic disorders, with expertise spanning chemotherapy, immunotherapy, radiation therapy, and investigational modalities including CAR T-cell and CAR-NK cell therapies.
Investors · 1
In the news
Frequently asked questions
- What does Vaximm do?
- VAXIMM is a clinical-stage biopharmaceutical company developing oral T-cell immunotherapies for cancer, based on technology invented at UC San Diego. Its lead candidate VXM01 has been evaluated in clinical trials for indications such as pancreatic cancer, and the company operates as a subsidiary of OSR Health.
- Who founded Vaximm?
- Vaximm was founded by Andreas Niethammer.
- Who are Vaximm's investors?
- Vaximm's investors include Sunstone Capital.